Made Scientific acquires cell therapy facility in Pennsylvania, US
The facility is positioned to supply therapies for clinical and commercial use in 2027.
Drug Development
EC approves Menarini and NewAmsterdam’s obicetrapib therapies
Telix to acquire ITM in deal worth up to $2.35bn
Sandoz and mAbxience agree on emicizumab biosimilar partnership
Ona Therapeutics to develop ADC with WuXi’s payload-linker platform
Roche agrees to $1bn deal with Dualitas for bispecific antibody research
Cellares and GenomeFrontier to assess automated GF-CART01 production
Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy
